FDA Advisers Oppose Repeated COVID-19 Vaccine Boosters

FDA wants to decide on whether to select strain-specific boosters by June

Syringes of COVID-19 vaccines in New Orleans, La., on Jan. 25, 2022. Ted Jackson/AP Photo

Experts who advise the U.S. Food and Drug Administration (FDA) on April 6 came out in opposition to a strategy of repeated COVID-19 vaccine boosters within a short period of time, during a meeting where FDA officials said they plan on deciding on the future vaccination strategy by June.

“I do not believe that booster every eight weeks or even four months is a long-term strategy for prevention,” Dr. Amanda Cohn, a Centers for Disease Control and Prevention official, said during a virtual meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee.